These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6064252)

  • 21. [Optimization of the dosage fields of a proton beam in treating cervical cancer].
    Reznik BI; Kiseleva VN
    Med Radiol (Mosk); 1981 Dec; 26(12):10-3. PubMed ID: 6275234
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of the Decatron gamma therapeutic apparatus in treating cervical cancer].
    Glazer FG
    Vopr Onkol; 1980; 26(10):56-9. PubMed ID: 7001746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unstable chromosome aberrations in peripheral blood lymphocytes from patients with cervical uterine cancer following radiotherapy.
    Magnata SP; Serafim I; Netto J; Gomes P; Netto AM; Amaral A
    Cell Mol Biol (Noisy-le-grand); 2002 Nov; 48(7):809-11. PubMed ID: 12619980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of treatment of cervical cancer using an apparatus for high-energy gamma-therapy].
    Stankevich AA; Frolova ZV; Protopopov PB; Mezentseva SK; Zmeeva LV
    Vopr Onkol; 1980; 26(11):59-62. PubMed ID: 6779423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Variability of dose distribution in intracavity irradiation of cancer of the cervix uteri using radium].
    Tacev T; Krystof V
    Cesk Radiol; 1984 May; 38(3):216-21. PubMed ID: 6744460
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical value of the Nominal Standard Dose (NSD) and Time-Dose Factor (TDF) in the evaluation of probability of cure and risk of complications in patients with cervical cancer treated with radium].
    Rattka P; Maciejewski B
    Pol Przegl Radiol Med Nukl; 1982; 46(5-6):281-6. PubMed ID: 7170254
    [No Abstract]   [Full Text] [Related]  

  • 27. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
    Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K; Jassem J
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Soft tissue sarcoma as a result of uterine cervix cancer radiotherapy].
    Karczmarek-Borowska B; Korobowicz E; Furmanik F; Sieracki A; Zdunek M; Sawicki M
    Wiad Lek; 2004; 57(7-8):388-91. PubMed ID: 15631199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late effects of radiation therapy for cancer of the uterine cervix.
    Zippin C; Lum D; Kohn HI; Bailar JC
    Cancer Detect Prev; 1981; 4(1-4):487-92. PubMed ID: 7349815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can intensity-modulated radiation therapy replace brachytherapy in the management of cervical cancer? Counterpoint.
    Mundt AJ; Roeske JC
    Brachytherapy; 2002; 1(4):192-4. PubMed ID: 15062166
    [No Abstract]   [Full Text] [Related]  

  • 32. Can intensity-modulated radiation therapy replace brachytherapy in the management of cervical cancer? Point.
    Alektiar KM
    Brachytherapy; 2002; 1(4):191-2. PubMed ID: 15062165
    [No Abstract]   [Full Text] [Related]  

  • 33. Computer tomography-assisted three-dimensional technique to assess rectal and bladder wall dose in intracavitary brachytherapy for uterine cervical cancer.
    Sun LM; Huang EY; Ko SF; Wang CJ; Leung SW; Lin H; Wu JM; Wu IH; Lee SP
    Radiother Oncol; 2004 Jun; 71(3):333-7. PubMed ID: 15172150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Variants of fractionation of irradiation in intracavitary gamma-therapy].
    Vishnevskaia EE; Danilova IA; Litvinova TM
    Vopr Onkol; 1980; 26(7):31-5. PubMed ID: 7405101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Importance of the TDF factor in planning the combined radiation therapy of cervical cancer and the assessment of complications].
    Kostromina KN; Fadeeva MA
    Med Radiol (Mosk); 1980 Jun; 25(6):57-63. PubMed ID: 7392836
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cancer of the uterine cervix: combination of radiotherapy and cisplatin chemotherapy (chemoradiotherapy) is superior to radiotherapy alone in local advanced stages].
    Mazeron JJ
    Bull Cancer; 1999 Mar; 86(3):247-8. PubMed ID: 10847719
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of combined radiotherapy on blood levels of ACTH, cortisol and aldosterone in cervical cancer].
    Modnikov OP
    Vopr Onkol; 1984; 30(3):37-40. PubMed ID: 6324489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Variability of a dose in external irradiation by a split field].
    Tacev T; Krystof V
    Cesk Radiol; 1980 May; 34(3):186-90. PubMed ID: 6772318
    [No Abstract]   [Full Text] [Related]  

  • 40. The weighted geometric center in the remote afterloading intracavitary therapy for carcinoma of the uterine cervix.
    Inoue T; Inoue T; Harada K; Hata K
    Strahlentherapie; 1982 Feb; 158(2):90-3. PubMed ID: 7064168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.